Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
A Prime Therapeutics analysis (2024) found GLP-1 use raised annual healthcare costs by 46% for obese patients in two years versus controls ( [71] ), mainly driven by drug spending
If you or anyone you know needs support, call Lifeline 131 114, Beyond Blue 1300 224 636, or PANDA between 9am and 7.30pm on 1300 726 306
Serving Size: 2 capsules Amount Per Serving: Resistant Potato Starch (Solnul)
Targeted Results Your provider can combine GHK-Cu with other regenerative treatments, such as microneedling or PRP therapy, to maximize collagen stimulation and healing
Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss
This absence of formal research means that any combined use is based on extrapolation from individual drug studies, theoretical pharmacology, and anecdotal clinical experience rather than robust evidence
